Sonus Networks Inc. (SONS) Jumps 27.7% on February 16

Equities Staff |

Sonus Networks Inc. (SONS) was among the biggest gainers on the Russell 2000 for Tuesday February 16 as the stock popped 27.7% to $6.80, representing a gain of $1.475 per share. Some 2.7 million shares traded hands on 13,915 trades, compared with an average daily volume of 637,204 shares out of a total float of 49.74 million. The stock opened at $5.90 and traded with an intraday range of $6.82 to $5.86.

After today's gains, Sonus Networks Inc. reached a market cap of $338.23 million. Sonus Networks Inc. has had a trading range between $18.38 and $5.15 over the last year, and it had a 50-day SMA of $6.32 and a 200-day SMA of $6.84.

Sonus Networks Inc is a provider of networked solutions for communications service. It is a supplier of Session Initiation Protocol-based communication equipment including VoIP, video and Unified Communications through IP networks.

Sonus Networks Inc. is based out of Westford, MA and has some 1,193 employees. Its CEO is Raymond P. Dolan.

For a complete fundamental analysis analysis of Sonus Networks Inc., check out’s Stock Valuation Analysis report for SONS. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Propanc Health Group Corp

Propanc Health Group Corp is an early stage healthcare company. It is engaged in developing new cancer treatments for patients, suffering from pancreatic and colorectal cancer.

Private Markets


Wealthfront is an automated investment service that serves as an alternative to traditional financial advisory services. The company manages a diversified, continually rebalanced portfolio of index funds on their clients’…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.